Skip to main content

Disclaimer

In the Downloads section, the ‘Prior Submission’ file reflects the most recent measure submission to the former CBE. This file is provided for transparency. For any questions or clarification, please contact the designated measure steward.

Febrile Neutropenia Risk Assessment Prior to Chemotherapy

CBE ID
2930
1.5 Project
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

Percentage of patients with a solid malignant tumor or lymphoma who had a febrile neutropenia (FN) risk assessment completed and documented in the medical record prior to the first cycle of intravenous chemotherapy

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      No
      1.8 Level of Analysis
      1.9 Care Setting
      1.14 Numerator

      Number of patients who had an FN risk assessment documented in the medical record prior to the first cycle of intravenous chemotherapy.

      1.15 Denominator

      Number of patients 18 years of age or older with a solid malignant tumor or lymphoma receiving the first cycle of intravenous chemotherapy.

      Exclusions

      There are no denominator exclusions.

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Cancer Spring Cycle 2021
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      University of Southern California
      Steward POC email
      Steward Organization Copyright

      Some proprietary codes are contained in the measure specifications for convenience of the user. Use of these codes may require permission from the code owner or agreement to a license.

      ICD-10 codes are copyrighted © World Health Organization (WHO), Fourth Edition, 2010. CPT © 2010 American Medical Association. CPT is a registered trademark of the American Medical Association. All rights reserved.

                Public Comments